期刊文献+

非酒精性脂肪肝病与冠状动脉粥样硬化相关CT影像标志物的研究进展

Research progress of CT imaging markers associated with nonalcoholic fatty liver disease and coronary atherosclerosis
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)已经发展成为全世界最常见的慢性肝脏疾病,并且发病率逐年增加。近年来,越来越多的研究证明,NAFLD与冠状动脉粥样硬化存在多种共同的病理生理学机制,如胰岛素抵抗、全身炎症,NAFLD可以促进冠状动脉粥样硬化的发生发展,与动脉粥样硬化心血管疾病密切相关,是动脉粥样硬化心血管疾病的独立危险因素。本文拟从NAFLD促进冠状动脉粥样硬化的病理生理学机制及NAFLD与冠状动脉粥样硬化影像标志物的相关研究两方面阐述NAFLD与动脉粥样硬化心血管疾病相关性的研究进展,旨在提高对早期冠状动脉粥样硬化危险因素的识别,为未来NAFLD和ASCVD的个体化临床诊疗及研究提供思路。 Non-alcoholic fatty liver disease(NAFLD)has emerged as the most prevalent chronic liver disease worldwide,with an increasing incidence on an annual basis.In recent years,a growing body of evidence indicates that NAFLD and coronary atherosclerosis share a multitude of pathophysiological mechanisms,including insulin resistance and systemic inflammation.NAFLD not only promotes the occurrence and development of coronary atherosclerosis,but also is closely related to atherosclerotic cardiovascular disease and represents an independent risk factor for this disease.This article aims to review the research progress of the correlation between NAFLD and atherosclerotic cardiovascular disease from two different but complementary perspectives,including the pathophysiological mechanism of NAFLD promoting coronary atherosclerosis and the correlation studies on imaging markers of NAFLD and coronary atherosclerosis,in order to enhance the identification of risk factors for early coronary atherosclerosis,and provide insights for future individualized clinical diagnosis,treatment and research of NAFLD and atherosclerotic cardiovascular disease.
作者 张瑜 刘俊诗 邢艳 ZHANG Yu;LIU Junshi;XING Yan(Imaging Center,The First Affiliate Hospital of Xinjiang Medical University,Urumqi 830011,China)
出处 《分子影像学杂志》 2024年第5期548-552,共5页 Journal of Molecular Imaging
基金 国家自然科学基金(82160334)。
关键词 非酒精性脂肪性肝病 冠状动脉粥样硬化 冠状动脉钙化 高危斑块 冠状动脉周围脂肪组织 non-alcoholic fatty liver disease coronary atherosclerosis coronary artery calcification high-risk plaque pericoronary adipose tissue
  • 相关文献

参考文献13

二级参考文献51

  • 1Mohamed H Ahmed,Christopher D Byrne.Obstructive sleep apnea syndrome and fatty liver: Association or causal link?[J].World Journal of Gastroenterology,2010,16(34):4243-4252. 被引量:8
  • 2Yu-Cheng Lin,Huey-Ming Lo,Jong-Dar Chen.Sonographic fatty liver, overweight and ischemic heart disease[J].World Journal of Gastroenterology,2005,11(31):4838-4842. 被引量:11
  • 3N Assy,I Bekirov,Y Mejritsky,L Solomon,S Szvalb,O Hussein.Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases[J].World Journal of Gastroenterology,2005,11(37):5834-5839. 被引量:4
  • 4Amedeo Lonardo,Silvia Lombardini,Federica Scaglioni,Stefano Ballestri,Anna Maria Verrone,Marco Bertolotti,Lucia Carulli,Dorval Ganazzi,Nicola Carulli,Paola Loria.Fatty liver,carotid disease and gallstones:A study of age-related associations[J].World Journal of Gastroenterology,2006,12(36):5826-5833. 被引量:14
  • 5Giuseppe Mancia,Robert Fagard,Krzysztof Narkiewicz,Josep Redon,Alberto Zanchetti,Michael B?hm,Thierry Christiaens,Renata Cifkova,Guy De Backer,Anna Dominiczak,Maurizio Galderisi,Diederick E. Grobbee,Tiny Jaarsma,Paulus Kirchhof,Sverre E. Kjeldsen,Stéphane Laurent,Athanasios J. Manolis,Peter M. Nilsson,Luis Miguel Ruilope,Roland E. Schmieder,Per Anton Sirnes,Peter Sleight,Margus Viigimaa,Bernard Waeber,Faiez Zannad,Josep Redon,Anna Dominiczak,Krzysztof Narkiewicz,Peter M. Nilsson.2013 ESH/ESC Guidelines for the management of arterial hypertension[J]. European Heart Journal . 2013 (28)
  • 6Derrick M. Van Rooyen,Lay T. Gan,Matthew M. Yeh,W. Geoffrey Haigh,Claire Z. Larter,George Ioannou,Narci C. Teoh,Geoffrey C. Farrell.Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome<!-- Doctopic: GMD -->[J].Journal of Hepatology.2013(1)
  • 7Marcello Ricardo Paulista Markus,Sebastian Edgar Baumeister,Jan Stritzke,Marcus D?rr,Henri Wallaschofski,Henry V?lzke,Wolfgang Lieb.Hepatic Steatosis Is Associated With Aortic Valve Sclerosis in the General Population: The Study of Health in Pomerania (SHIP)[J].Arteriosclerosis Thrombosis and Vascular Biology.2013(7)
  • 8Matti J. Tikkanen,Rana Fayyad,Ole Faergeman,Anders G. Olsson,Chuan-Chuan Wun,Rachel Laskey,John J. Kastelein,Ingar Holme,Terje R. Pedersen.Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels[J].International Journal of Cardiology.2013
  • 9Giovanni Targher,Christopher D. Byrne.Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications[J].The Journal of Clinical Endocrinology & Metabolism.2013(2)
  • 10Lucia Carulli,Mauro Maurantonio,Lionel Hebbard,Enrica Baldelli,Paola Loria,Jacob George.Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD[J].Current Pharmaceutical Design.2013(29)

共引文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部